Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of PD‐L1 and PD‐L2

Post time 2024-4-29 16:54:46

journal：Head & Neck

Authors：Ryosuke Sato; Hiroki Komatsuda; Takahiro Inoue; Risa Wakisaka; Michihisa Kono; Hidekiyo Yamaki; Kenzo Ohara; Takumi Kumai; Kan Kishibe; Tatsuya Hayashi; Miki Takahara

Published date：--

DOI：10.1002/hed.27787

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hed.27787

Article link：http://dx.doi.org/10.1002/hed.27787

Article Source：Wiley。

Remark：

Post time 2024-4-29 16:54:47

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Wiley] Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of PD‐L1 and PD‐L2

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Wiley] Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of PD‐L1 and PD‐L2 Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Wiley] Combined approach for predicting the efficacy of nivolumab in head and neck carcinoma by tissue and soluble expressions of PD‐L1 and PD‐L2